Lebenthal Asset Management’s GSK GSK Stock Holding History

Lebenthal Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$388K	Buy	+11,890	New	+$603K	0.05%	275

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lebenthal Asset Management's GSK Position: Q1 2017 in Review

Lebenthal Asset Management opened a new position in GSK (GSK) in Q1 2017: 11,890 shares worth $388K. The stake represents 0.05% of the portfolio and ranks #275 among its holdings.

786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Lebenthal Asset Management held 11,890 shares of GSK worth $388K as of Q1 2017.
GSK was a new Lebenthal Asset Management position in Q1 2017.
GSK made up 0.05% of Lebenthal Asset Management's portfolio in Q1 2017, its #275 holding.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.